• GRADUATE STUDENT | Graduate School of Biomedical Sciences

Research Topics:

Anti-Tumor Therapy, Cancer, Cancer Genetics, Cell Biology, Cell Transformation, DNA Recombination, DNA Repair, DNA Replication, Gene Therapy, Gene editing, Genomics, Immunology, Molecular Biology, Nanotechnology, Personalized Medicine, Protein Kinases, Protein Phosphatases, RNA, RNA Splicing & Processing, RNA Transport & Localization, T Cells, Technology & Innovation, Translational Research, Tumorigenesis, Viruses and Virology

Matthew Lin is a current first-year MD/PhD student in the CAB multidisciplinary training are at the Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai. Matthew has interest in integrating genetic engineering with personalized care to provide and improve cancer treatments for all patients. 


Matthew graduated from the University of Connecticut in 2018 with a B.S. in Biological Sciences and an M.S. in Genetics & Genomics.


He was designated a University Scholar and Nutmeg STEM Scholar while at UConn and was a finalist for both the Innovation Quest InQbator program and the 2018 Mount Sinai Health Hackathon. In addition to undergraduate research in medicinal chemistry and liver physiology, Matthew has experience in developing a CRISPR/Cas9 therapy for cancer that culminated in a pending patent. He is also interested in entrepreneurship and is pursuing a medical device with the Mount Sinai Innovation Partners as a result of the Health Hackathon. Outside of the lab and clinic, he is an avid cook, graphic designer, athlete, and cellist. 

Multi-Disciplinary Training Area

Cancer Biology [CAB]